Ultra-rapid screening for substance-use disorders: The Alcohol, Smoking and Substance Involvement Screening Test (ASSIST-Lite)

Ali, Robert; Meena, Sonali; Eastwood, Brian J.; Richards, Ian; Marsden, John

doi:10.1016/j.drugalcdep.2013.03.001

Cited by 104 publications

(77 citation statements)

References 27 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Regarding the level of evidence, the higher prevalence studies referred to those with level IV, that is, cross-sectional studies, which corresponded to 69.2% of the sample (2,(4)(5)(6)(7)(8)(9)(10)16,(18)(19)(20)(23)(24)(27)(28)(29)33) . Many professionals proceeded to the implementation of ASSIST and among them, we highlight different health professionals (53.8%) (5,7,10,(17)(18)(19)21,(23)(24)(25)(26)28,(31)(32) , followed by trained individuals named as interviewers (34.6%) (2,6,8,11,20,22,27,33) , and researchers (authors), which corresponded to 11,5% (9,16,25) . Regarding the database which the studies were obtained, 34.6% (5,7,11,(16)(17)…”

Section: Resultsmentioning

confidence: 99%

“…Many professionals proceeded to the implementation of ASSIST and among them, we highlight different health professionals (53.8%) (5,7,10,(17)(18)(19)21,(23)(24)(25)(26)28,(31)(32) , followed by trained individuals named as interviewers (34.6%) (2,6,8,11,20,22,27,33) , and researchers (authors), which corresponded to 11,5% (9,16,25) . Regarding the database which the studies were obtained, 34.6% (5,7,11,(16)(17)(18)21,23,26) were from PubMed, followed by the CAPES Journal Portal with 26.9% (2,20,22,25,(31)(32)(33) , SciELO with 19.2% (19,24,(27)(28)(29) , LILACS with 15.4% (6,8,9,…”

Section: Resultsmentioning

confidence: 99%

“…This IRL shows that 34.6% (5,7,11,(16)(17)(18)(19)(20)(21) of the studies came from the PubMed database, followed by CAPES Journals with 26.9% (2,(21)(22)(23)(24)(25)(26) , SciELO with 19.2% (19,24,(27)(28)(29) , Lilacs, with 15.4% (6,(8)(9)30) and Medline, with 3.8% (10) , 19 studies were duplicated in these databases. After selection, 26 studies were intended for analysis.…”

Section: Resultsmentioning

confidence: 99%

“…The application was conducted in heterogeneous groups with adult prevalence (73.1%) (2,(5)(6)(7)(8)(9)11,17,(20)(21)(22)(23)(24)(25)(26)(27)(30)(31)(32)(33) , followed by young students (15.4%) (16,17,19,28) , adolescents (7.7%) (10,29) and elderly (3.8%) (17) . Regarding the level of evidence, the higher prevalence studies referred to those with level IV, that is, cross-sectional studies, which corresponded to 69.2% of the sample (2,(4)(5)(6)(7)(8)(9)(10)16,(18)(19)(20)(23)(24)(27)(28)(29)33) .…”

Section: Resultsmentioning

confidence: 99%

See 3 more Smart Citations

Aplicação do instrumento Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): uma revisão integrativa

Silva

Lucchese

Vargas

et al. 2016

Rev. Gaúcha Enferm.

View full text Add to dashboard Cite

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

See 2 more Smart Citations

Aplicação do instrumento Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): uma revisão integrativa

Silva

Lucchese

Vargas

et al. 2016

Rev. Gaúcha Enferm.

View full text Add to dashboard Cite

show abstract

“…Participants receive a small gift valued at $1.00 (e.g., headphones, water bottle, smartphone armband) for completing the screening survey. Those who report past month binge drinking or marijuana use and have access to their smartphone while in the Emergency Department provide written consent/assent self-administer a 129-question baseline survey with items about: (a) past-month substance use frequency and consequences [83,84,85]; (b) past-month violence involvement, injury, risky sex behaviors [6,86,87,88,89]; (c) coping and mindfulness [90,91]; (d) motivation/self-efficacy to reduce their alcohol and marijuana use [92,93].…”

Section: Baseline Proceduresmentioning

confidence: 99%

Toward Increasing Engagement in Substance Use Data Collection: Development of the Substance Abuse Research Assistant App and Protocol for a Microrandomized Trial Using Adolescents and Emerging Adults (Preprint)

Rabbi¹,

Philyaw-Kotov²,

Cunningham³

et al. 2018

Preprint

View full text Add to dashboard Cite

BACKGROUND Substance use is an alarming public health issue associated with significant morbidity and mortality. Adolescents and emerging adults are at particularly high risk because substance use typically initiates and peaks during this developmental period. Mobile health apps are a promising data collection and intervention delivery tool for substance-using youth as most teens and young adults own a mobile phone. However, engagement with data collection for most mobile health applications is low, and often, large fractions of users stop providing data after a week of use. OBJECTIVE Substance Abuse Research Assistant (SARA) is a mobile application to increase or sustain engagement of substance data collection overtime. SARA provides a variety of engagement strategies to incentivize data collection: a virtual aquarium in the app grows with fish and aquatic resources; occasionally, funny or inspirational contents (eg, memes or text messages) are provided to generate positive emotions. We plan to assess the efficacy of SARA’s engagement strategies over time by conducting a micro-randomized trial, where the engagement strategies will be sequentially manipulated. METHODS We aim to recruit participants (aged 14-24 years), who report any binge drinking or marijuana use in the past month. Participants are instructed to use SARA for 1 month. During this period, participants are asked to complete one survey and two active tasks every day between 6 pm and midnight. Through the survey, we assess participants’ daily mood, stress levels, loneliness, and hopefulness, while through the active tasks, we measure reaction time and spatial memory. To incentivize and support the data collection, a variety of engagement strategies are used. First, predata collection strategies include the following: (1) at 4 pm, a push notification may be issued with an inspirational message from a contemporary celebrity; or (2) at 6 pm, a push notification may be issued reminding about data collection and incentives. Second, postdata collection strategies include various rewards such as points which can be used to grow a virtual aquarium with fishes and other treasures and modest monetary rewards (up to US $12; US $1 for each 3-day streak); also, participants may receive funny or inspirational content as memes or gifs or visualizations of prior data. During the study, the participants will be randomized every day to receive different engagement strategies. In the primary analysis, we will assess whether issuing 4 pm push-notifications or memes or gifs, respectively, increases self-reporting on the current or the following day. RESULTS The microrandomized trial started on August 21, 2017 and the trial ended on February 28, 2018. Seventy-three participants were recruited. Data analysis is currently underway. CONCLUSIONS To the best of our knowledge, SARA is the first mobile phone app that systematically manipulates engagement strategies in order to identify the best sequence of strategies that keep participants engaged in data collection. Once the optimal strategies to collect data are identified, future versions of SARA will use this data to provide just-in-time adaptive interventions to reduce substance use among youth. CLINICALTRIAL ClinicalTrials.gov NCT03255317; https://clinicaltrials.gov/show/NCT03255317 (Archived by WebCite at http://www.webcitation.org/70raGWV0e) REGISTERED REPORT IDENTIFIER RR1-10.2196/9850

show abstract

Feasibility randomized‐controlled trial of online acceptance and commitment therapy for painful peripheral neuropathy in people living with HIV: The OPEN study

Scott

Guildford

Badenoch

et al. 2021

European Journal of Pain

View full text Add to dashboard Cite

show abstract

Ultra-rapid screening for substance-use disorders: The Alcohol, Smoking and Substance Involvement Screening Test (ASSIST-Lite)

Cited by 104 publications

References 27 publications

Aplicação do instrumento Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): uma revisão integrativa

Aplicação do instrumento Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): uma revisão integrativa

Toward Increasing Engagement in Substance Use Data Collection: Development of the Substance Abuse Research Assistant App and Protocol for a Microrandomized Trial Using Adolescents and Emerging Adults (Preprint)

Feasibility randomized‐controlled trial of online acceptance and commitment therapy for painful peripheral neuropathy in people living with HIV: The OPEN study

Contact Info

Product

Resources

About